The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro

Journal of Neuroimmunology

Volumn 159, Issue 1-2, 2005, Pages 97-105

  Sacerdote, P ^a   Martucci, C ^a   Vaccani, A ^b   Bariselli, F ^a   Panerai, A E ^a   Colombo, A ^a   Parolaro, D ^b   Massi, P ^a  

^a Department of Pharmacology ^*  (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Cannabidiol; Chemotaxis; IL 10; IL 12; Macrophage; Marijuana

Indexed keywords

5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABIDIOL; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; INTERLEUKIN 10; INTERLEUKIN 12; RIMONABANT;

ANIMAL CELL; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFECT; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; BORNANES; CANNABIDIOL; CELL MIGRATION INHIBITION; CELLS, CULTURED; CHEMOTAXIS; CYTOKINES; DOWN-REGULATION; INTERLEUKIN-10; INTERLEUKIN-12; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; UP-REGULATION;

EID: 12344250051     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.10.003     Document Type: Article

References (48)

1. G.A. Cabral, and D.A. Dove-Pettit Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease J. Neuroimmunol. 83 1998 116 123
2. S.J. Carlisle, F. Marciano Cabral, A. Staab, C. Ludwick, and G.A. Cabral Differential expression of the CB2 receptor by rodent macrophages and macrophage-like cells in relation to cell activation Int. Immunopharmacol. 2 2002 69 82
3. Y. Chen, and J. Buck Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism J. Pharmacol. Exp. Ther. 293 2000 807 812
4. S. Chuchawankul, M. Shima, N.E. Buckley, C.B. Hartmann, and K.L. McCoy Role of cannabinoid receptors in inhibiting macrophage costimulatory activity Int. Immunopharmacol. 4 2004 265 278
5. D.R. Compton, M.D. Aceto, J. Lowe, and B.R. Martin In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of Δ9-tetrahydrocannabinol-induced responses and apparent agonistic activity J. Pharmacol. Exp. Ther. 277 1996 586 594
6. T. Croci, M. Landi, A.M. Galzin, and P. Marini Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (Rimonabant) in rodents Br. J. Pharmacol. 140 2003 115 122
7. S. Galiegue, S. Mary, J. Marchand, D. Dussossoy, D. Carriere, P. Carayon, M. Bouaboula, D. Shire, G. Le Fur, and P. Casellas Expression of central and peripheral cannabinoid receptor in human tissue and leukocyte subpopulation Eur. J. Biochem. 232 1995 54 61
8. Z. Jarai, J.A. Wagner, K.D. Varga, D.R. Compton, B.R. Martin, A.M. Zimmer, T.I. Bonner, N.E. Buckley, R.K. Razdan, A. Zimmer, and G. Kunos Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors Proc. Natl. Acad. Sci. U. S. A. 96 1999 14136 14141
9. N.E. Kaminski Regulation of the cAMP cascade, gene expression and immune function by cannabinoid receptors J. Neuroimmunol. 83 1998 124 132
10. N.E. Kaminski, M.E. Abood, F.K. Kessler, B.R. Martin, and A.R. Schatz Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation Mol. Pharmacol. 42 1992 736 742
11. J. Killestein, E.L.J. Hoogervost, M. Reif, B. Blauw, M. Smits, B.M.J. Uitdehaag, L. Nagelkerken, and C.H. Polman Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis J. Neuroimmunol. 137 2003 140 143
12. W.K. Klein, C. Newton, and H. Friedman Cannabinoid receptors and immunity Immunol. Today 19 1998 373 381
13. T.W. Klein, C.A. Newton, N. Nakachi, and H. Friedman delta-9- Tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12 and IL-12 receptor beta-2 responses to Legionella pneumophila infection J. Immunol. 15 2000 6461 6466
14. T.W. Klein, C.A. Newton, K. Larsen, J. Chou, I. Perkins, L. Lu, L. Nong, and H. Friedman Cannabinoid receptors and T helper cells J. Neuroimmunol. 147 2004 91 94
15. R.S. Landsman, T.H. Burkey, P. Consroe, W.R. Roeske, and H.I. Yamamura SR141716A is an inverse agonist of the human cannabinoid receptor Eur. J. Pharmacol. 334 1997 R-1 R-2
16. E. Limiroli, L. Gaspani, A.E. Panerai, and P. Sacerdote Differential tolerance development in the modulation of macrophage cytokine production in mice J. Leukoc. Biol. 72 2002 43 48
17. J. Liu, S. Batkai, P. Pacher, J. Harvey White, J.A. Wagner, B.F. Vravatt, B. Gao, and G. Kunos Lipopolysaccaride induces anandamide synthesis in macrophages via CD14/MapK/phosphoinositide 3-kinase/NF-kappab independently of platelet activator factor J. Biol. Chem. 278 2003 45034 45039
18. A.M. Malfait, R. Gallily, P.F. Sumariwalla, A.S. Malik, N.E. Andreakos, R. Mechoulam, and M. Feldmann The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen induced arthritis Proc. Natl. Acad. Sci. U. S. A. 97 2000 9561 9566
19. P. Massi, P. Sacerdote, W. Ponti, D. Fuzio, B. Manfredi, D. Vigano', T. Rubino, M. Bardotti, and D. Parolaro Immune function alterations in mice tolerant to tetraidrocannabinol: functional and biochemical parameters J. Neuroimmunol. 92 1998 60 66
20. P. Massi, D. Fuzio, D. Vigano', P. Sacerdote, and D. Parolaro Relative involvement of cannabinoid CB1 and CB2 receptors in the Δ9- tetrahydrocannabinol-induced inhibition of natural killer activity Eur. J. Pharmacol. 387 2000 343 347
21. P. Massi, A. Vaccani, P. Sacerdote, and D. Parolaro Effects of cannabidiol, a non psychoactive constituent of marijuna on immune system 12th Annual Symposium on the Cannabinoids (ICRS) Pacific Grove, CA, USA, Abstract 2002 43
22. P. Massi, A. Vaccani, S. Ceruti, A. Colombo, M.P. Abbracchio, and D. Parolaro Antitumor effects of cannabidiol a nonpshychoactive cannabinoid, on human glioma cell lines J. Pharmacol. Exp. Ther. 308 2004 838 845
23. I. Matias, P. Pochard, P. Orlando, M. Salzet, J. Pestel, and V. Di Marzo Presence and regulation of the endocannabinoid system in human dendritic cells Eur. J. Biochem. 269 2002 3771 3778
24. K.W. Moore, A. O Garra, R. De Waal Malefyt, P. Vieira, and T.R. Mosman Interleukin-10 Annu. Rev. Immunol. 11 1993 165 190
25. T.R. Mosman, and S. Sad The expanding universe of T-cell subsets; Th1, Th2 and more Immunol. Today 17 1996 138 146
26. C. Newton, T. Klein, and H. Friedman The role of macrophages in THC-induced alteration of the cytokine network Adv. Exp. Med. Biol. 437 1998 207 2014
27. G. Patrini, P. Sacerdote, D. Fuzio, B. Manfredi, and D. Parolaro Regulation of immune functions in rat splenocytes after acute and chronic in vivo treatment with CP-55,940, a synthetic cannabinoid compound J. Neuroimmunol. 80 1997 143 148
28. R.G. Pertwee Pharmacology of cannabinoid receptor ligands Curr. Med. Chem. 68 1999 635 664
29. R.G. Pertwee, R.A. Ross, S.J. Craib, and A. Thomas (-)-Cannabidiol antagonizes cannabidiol receptor agonista and noradrenaline in the mouse deferens Eur. J. Pharmacol. 456 2002 99 106
30. M. Portier, M. Rinaldi-Carmona, F. Pecceu, T. Combes, C. Poinot-Chazel, B. Calandra, F. Barth, G. Le Fur, and P. Casellas SR 144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist J. Pharmacol. Exp. Ther. 288 1999 582 589
31. O. Pozzi, P. Misiano, G.D. Clark, and L. Visentin Antagonism between the Antiinflammatory Activity of Th Cannabinoid WIN 55212-2 and SR141716A 2003
32. E.R. Prossnitz, and R.D. Ye The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function Pharmacol. Ther. 74 1997 73 102
33. M. Rinaldi Carmona, F. Barth, M. Heaulme, D. Shire, B. Calandra, C. Congy, S. Martinez, J. Maruani, G. Neliat, D. Caput, P. Ferrara, P. Soubrie', J.C. Breliere, and G. Le Fur SR 141716A a potent and selective antagonist of the brain cannabinoid receptor FEBS Lett. 350 1994 240 244
34. M. Rinaldi-Carmona, F. Barth, M. Heaulme, R. Alonso, D. Shire, C. Congy, P. Soubrie, J.C. Breliee, and G. Le Fur Biochemical and pharmacological characterization of SR141716A, the first potent and selective brain cannabinoid receptor antagonist Life Sci. 26 1995 1941 1947
35. M. Rinaldi Carmona, F. Barth, J. Millan, J.M. Derocq, P. Casellas, C. Chongy, D. Oustric, M. Sarran, M. Bouaboula, B. Calandra, M. Portier, D. Shire, J.C. Breliere, and G. Le Fur SR 144528 the first potent and selective antagonist of the CB2 cannabinoid receptor J. Pharmacol. Exp. Ther. 284 1998 644 650
36. P. Sacerdote, B. Manfredi, L. Gaspani, and A.E. Panerai The opioid antagonist naloxone induces a shift from type 1 cytokine pattern to type 2 cytokine pattern in balb/cJ mice Blood 95 2000 2031 2036
37. P. Sacerdote, P. Massi, A.E. Panerai, and D. Parolaro In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors J. Neuroimmunol. 109 2001 155 163
38. P. Sacerdote, E. Limiroli, and L. Gaspani Experimental evidence for immunomodulatory effects of opioids H. Machelska C. Stein Immune Mechanisms of Pain and Analgesia Advances in Experimental Medicine and Biology vol. 521 2001 Kluwer Academic New York 106 112
39. E. Schiffmann Leukocyte chemotaxis Annu. Rev. Physiol. 44 1982 553 573
40. S.R. Smith, C. Terminelli, and G. Denhart Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and antiinflammatory inteleukin-10 in endotoxemic mice J. Pharmacol. Exp. Ther. 293 2000 136 150
41. M.D. Srivastava, B.I.S. Srivastava, and B. Brouhard Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells Immunopharmacology 40 1998 179 185
42. S.E. Straus Immunoactive cannabinoids: therapeutics prospects for marijuana constituents Proc. Natl. Acad. Sci. 97 2000 9363 9364
43. G. Trincheri Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen specific adaptive immunity Annu. Rev. Immunol. 13 1995 251 276
44. K. Varga, J.A. Wagner, D.T. Bridgen, and G. Kunos Platelet- and macrophage derived cannabinoids are involved in endotoxin-induced hypotension FASEB J. 12 1998 1035 1044
45. S.M. Wahl Inflammation and wound healing J. Oppenheim D. Rosenstreich M. Potter Cellular Functions in Immunity and Inflammation 1981 Elsevier/North Holland New York, NY 55 85
46. I. Walter, A. Franklin, A. Witting, C. Wade, Y. Xie, G. Kunos, K. Mackie, and N. Stella Nonpsychotropic cannabinoid receptor regulate microglial cell migration J. Neurosci. 23 2003 1398 1405
47. K. Watanabe, Y. Kayano, T. Matsunaga, I. Yamamoto, and H. Yoshimura Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids Biol. Pharm. Bull. 19 1996 1109 1111
48. K. Wenzel-Seifert, C.M. Hurt, and R. Seifert High constitutive activity of the human formyl peptide receptor J. Biol. Chem. 273 1998 24181 24189